Literature DB >> 22386326

Endemic mycoses: overlooked causes of community acquired pneumonia.

Chadi A Hage1, Kenneth S Knox, Lawrence J Wheat.   

Abstract

The endemic mycoses are important but often overlooked causes for community acquired pneumonia. Delays in recognition, diagnosis and proper treatment often lead to disastrous outcomes. This topic is not usually discussed in reviews and guidelines addressing the subject of community acquired pneumonia. In this review we discuss the three major endemic mycoses in North America that present as community acquired pneumonias; Coccidioidomycosis, Histoplasmosis and Blastomycosis. We discuss their epidemiology, clinical presentations, methods of diagnosis and current treatment strategies. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22386326     DOI: 10.1016/j.rmed.2012.02.004

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  23 in total

1.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

2.  Histoplasmosis-related Healthcare Use, Diagnosis, and Treatment in a Commercially Insured Population, United States.

Authors:  Kaitlin Benedict; Karlyn D Beer; Brendan R Jackson
Journal:  Clin Infect Dis       Date:  2020-03-03       Impact factor: 9.079

3.  Diagnostic delay in pulmonary blastomycosis: a case series reflecting a referral center experience.

Authors:  Aysun Tekin; Yuliya Pinevich; Vitaly Herasevich; Brian W Pickering; Paschalis Vergidis; Ognjen Gajic; John C O'Horo
Journal:  Infection       Date:  2022-07-01       Impact factor: 3.553

4.  Progress Toward a Human Vaccine Against Coccidioidomycosis.

Authors:  Garry T Cole; Brady J Hurtgen; Chiung-Yu Hung
Journal:  Curr Fungal Infect Rep       Date:  2012-12-01

Review 5.  Endemic Mycoses in Solid Organ Transplant Recipients.

Authors:  Jeremy S Nel; Luther A Bartelt; David van Duin; Anne M Lachiewicz
Journal:  Infect Dis Clin North Am       Date:  2018-09       Impact factor: 5.982

6.  Use of Fungal Diagnostics and Therapy in Pediatric Cancer Patients in Resource-Limited Settings.

Authors:  Sheena Mukkada; Jeannette Kirby; Nopporn Apiwattanakul; Randall T Hayden; Miguela A Caniza
Journal:  Curr Clin Microbiol Rep       Date:  2016-04-18

7.  Quantitative Microplate-Based Growth Assay for Determination of Antifungal Susceptibility of Histoplasma capsulatum Yeasts.

Authors:  Kristie D Goughenour; Joan-Miquel Balada-Llasat; Chad A Rappleye
Journal:  J Clin Microbiol       Date:  2015-08-05       Impact factor: 5.948

Review 8.  Diffuse cystic lung diseases.

Authors:  Jay H Ryu; Xinlun Tian; Misbah Baqir; Kaifeng Xu
Journal:  Front Med       Date:  2013-05-11       Impact factor: 4.592

Review 9.  Primary immunodeficiencies underlying fungal infections.

Authors:  Fanny Lanternier; Sophie Cypowyj; Capucine Picard; Jacinta Bustamante; Olivier Lortholary; Jean-Laurent Casanova; Anne Puel
Journal:  Curr Opin Pediatr       Date:  2013-12       Impact factor: 2.856

10.  Symptoms in Blastomycosis, Coccidioidomycosis, and Histoplasmosis Versus Other Respiratory Illnesses in Commercially Insured Adult Outpatients-United States, 2016-2017.

Authors:  Kaitlin Benedict; Miwako Kobayashi; Shikha Garg; Tom Chiller; Brendan R Jackson
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.